Teworte, Sarah

ORCID: 0000-0001-5074-1614 · 8 papers in corpus · active 2022-2026

Study types

  • article 6
  • other 1
  • preprint 1

Condition tags

  • endometriosis 8
  • infertility 2
  • mesh:D004715 1
other 2026
Small (Weinheim an der Bergstrasse, Germany) ·doi:10.1002/smll.202409126

This study advances sustainable pharmaceutical research for endometriosis by developing in vitro 3D cell culture models of endometriotic pathophysiology that allow antifibrotic drug candidates to be tested. Fibrosis is a key aspect of endom…

article 2025
·doi:10.48620/85825

This study advances sustainable pharmaceutical research for endometriosis by developing in vitro 3D cell culture models of endometriotic pathophysiology that allow antifibrotic drug candidates to be tested. Fibrosis is a key aspect of endom…

preprint 2024
·doi:10.1101/2024.10.05.616776

Abstract This study advances sustainable pharmaceutical research for endometriosis by aligning with the UN Sustainable Development Goals on health, gender equality, and responsible consumption in developing in vitro 3D cell culture models o…

article 2023
·doi:10.48350/179536
article 2023
·doi:10.5281/zenodo.7213433

Gynaecological health is a neglected field of research that includes conditions such as endometriosis, uterine fibroids, infertility, viral and bacterial infections, and cancers. There is a clinical need to develop dosage forms for gynecolo…

article 2023
·doi:10.48350/183579
article 2022
·doi:10.1002/hlca.202200132

Abstract In this perspective, we provide a broad overview of pathophysiological processes involved in endometriosis, including the role of inflammation, fibrosis, angiogenesis, hormonal regulation, and genetic factors. For each of the funct…

article 2022
·doi:10.5281/zenodo.7213434

Gynaecological health is a neglected field of research that includes conditions such as endometriosis, uterine fibroids, infertility, viral and bacterial infections, and cancers. There is a clinical need to develop dosage forms for gynaecol…